Investigational Drug Information for Cadazolid
✉ Email this page to a colleague
What is the development status for investigational drug Cadazolid?
Cadazolid is an investigational drug.
There have been 5 clinical trials for Cadazolid.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 27th 2014.
The most common disease conditions in clinical trials are Clostridium Infections, Diarrhea, and Infection. The leading clinical trial sponsors are Actelion and [disabled in preview].
Summary for Cadazolid
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 36 |
WIPO Patent Applications | 20 |
Japanese Patent Applications | 5 |
Clinical Trial Progress | Phase 3 (2014-03-27) |
Vendors | 37 |
Recent Clinical Trials for Cadazolid
Title | Sponsor | Phase |
---|---|---|
Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD) | Actelion | Phase 2/Phase 3 |
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea | Actelion | Phase 3 |
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea | Actelion | Phase 3 |
Clinical Trial Summary for Cadazolid
Top disease conditions for Cadazolid
Top clinical trial sponsors for Cadazolid
US Patents for Cadazolid
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |